Literature DB >> 15283349

Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome.

Shunji Sano1, Kozo Ishino, Masaaki Kawada, Osami Honjo.   

Abstract

This article reviews our experience using a prosthetic conduit between the right ventricle (RV) and the pulmonary artery (PA), in lieu of the more traditional aortopulmonary shunt, for infants undergoing surgical palliation of hypoplastic left heart syndrome. Thirty-three consecutive infants underwent Norwood procedure between February 1998 and November 2003, using an RV-PA conduit. There were 31 hospital survivors (94%) and 25 patients have undergone a stage II bidirectional Glenn anastomosis with an additional two deaths. Nine patients have undergone completion Fontan. This technique provides reproducible results, simplifies postoperative management, and improves outcome, especially for "low volume" programs.

Entities:  

Mesh:

Year:  2004        PMID: 15283349     DOI: 10.1053/j.pcsu.2004.02.023

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu        ISSN: 1092-9126


  15 in total

1.  Rudimentary right ventricle to pulmonary artery shunt in the Norwood procedure.

Authors:  Atsushi Tateishi; Masaaki Kawada; Hideki Morita; Mamoru Takeuchi; Naoyuki Taga; Yoji Otsuka; Osamu Okada; Koichi Kataoka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-12-18

2.  Univentricular heart: management options.

Authors:  Usha Krishnan
Journal:  Indian J Pediatr       Date:  2005-06       Impact factor: 1.967

3.  Effect of ventriculotomy on right-ventricular remodeling in hypoplastic left heart syndrome: a histopathological and echocardiography correlation study.

Authors:  Shaji C Menon; Lance K Erickson; Molly McFadden; Dylan V Miller
Journal:  Pediatr Cardiol       Date:  2012-08-09       Impact factor: 1.655

4.  Perioperative care of the infant with single ventricle physiology.

Authors:  Vamsi V Yarlagadda; Melvin C Almodovar
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

5.  Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience.

Authors:  S P McGuirk; M Griselli; O F Stumper; E M Rumball; P Miller; R Dhillon; J V de Giovanni; J G Wright; D J Barron; W J Brawn
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

Review 6.  Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.

Authors:  Richard G Ohye; Dietmar Schranz; Yves D'Udekem
Journal:  Circulation       Date:  2016-10-25       Impact factor: 29.690

Review 7.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

8.  Right-ventricular global longitudinal strain may predict neo-aortic arch obstruction after Norwood/Sano procedure in children with hypoplastic left heart syndrome.

Authors:  Frank J Raucci; Michael D Seckeler; Christine Saunders; James J Gangemi; Benjamin B Peeler; K Anitha Jayakumar
Journal:  Pediatr Cardiol       Date:  2013-05-07       Impact factor: 1.655

Review 9.  Left ventricle after palliation of hypoplastic left heart syndrome: friend, fiend, or innocent bystander?

Authors:  Jeffrey H Shuhaiber; Frank A Pigula
Journal:  Pediatr Cardiol       Date:  2013-03-22       Impact factor: 1.655

10.  Characterization of Post-Operative Hemodynamics Following the Norwood Procedure Using Population Data and Multi-Scale Modeling.

Authors:  Jonathan Primeaux; Arash Salavitabar; Jimmy C Lu; Ronald G Grifka; C Alberto Figueroa
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.